scispace - formally typeset
L

Lucía González-Ruiz

Researcher at University of Granada

Publications -  44
Citations -  818

Lucía González-Ruiz is an academic researcher from University of Granada. The author has contributed to research in topics: Cyclin D1 & Oral lichen planus. The author has an hindex of 11, co-authored 43 publications receiving 374 citations.

Papers
More filters
Journal ArticleDOI

Worldwide prevalence of oral lichen planus: a systematic review and meta‐analysis

TL;DR: It is proposed that reliable diagnostic criteria should be defined, which should include a set of essential criteria including the presence of white reticular lesions in any location of the oral mucosa, to determine the presence or absence of epithelial dysplasia.
Journal ArticleDOI

Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis.

TL;DR: The malignant transformation rates of OLP, OLLs and LRs are underestimated due essentially to restrictive diagnostic criteria, inadequate follow-up periods, and/or low quality of studies.
Journal ArticleDOI

An update on the implications of cyclin D1 in oral carcinogenesis.

TL;DR: This is the first published review of the specific features of cyclin D1 overexpression in oral oncogenesis and the implications of the oncogenic activation of CCND1/cyclin D 1 in oral squamous cell carcinoma.
Journal ArticleDOI

Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis.

TL;DR: A meta-analysis found a worse prognosis in OSCCs overexpressing PD-L1 in the cell membrane as measured by disease specific survival and disease-free survival and found positive correlations between PD- L1 overexpression and advanced tumours, females, non-smokers,non-drinkers and high levels of tumour PD-1, CD4, and CD8.
Journal ArticleDOI

Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis.

TL;DR: Findings indicate that immunohistochemical assessment of CD1 overexpression may be useful as a prognostic biomarker for OSCC and found effect of small studies on T and N status.